List view / Grid view
3 June 2016 | By Victoria White, Digital Content Producer
Researchers have identified an enzyme, Nek1, that separates DNA replication from repair. The discovery could be significant in the treatment of tumours...
2 June 2016 | By Victoria White, Digital Content Producer
The new collaboration builds on an earlier agreement with LUMC that gave Bellicum worldwide rights to TCR product candidates targeting solid tumours...
2 June 2016 | By Victoria White, Digital Content Producer
Researchers have initiated a new preclinical study aimed at developing a vaccine for the treatment of glioblastoma multiforme using ImmunoBody technology...
1 June 2016 | By Victoria White, Digital Content Producer
Incyte has agreed to provide funding to conduct three new Moffitt Cancer Centre research programmes over a period of three years...
31 May 2016 | By Victoria White, Digital Content Producer
Researchers from 39 institutions have examined 91 adrenal cancer samples to identify new genetic drivers of adrenal cancer...
26 May 2016 | By Victoria White, Digital Content Producer
Faron aims to extend the range of Clevegen indications through a technology platform called “Tumour Immunity Enabling Technology”, or TIET...
26 May 2016 | By Victoria White, Digital Content Producer
Scientists have found that a widely prescribed painkiller, celecoxib, slows the growth rate of a specific kind of cancer in animal models...
26 May 2016 | By Victoria White, Digital Content Producer
A bacteriophage, found in a pond in Connecticut, attacks a common multi-drug resistant bacterial pathogen called Pseudomonas aeruginosa...
25 May 2016 | By Victoria White, Digital Content Producer
The company’s lead product Cilcane (generic name cilengitide) is being repurposed by Iceni as a first-in-class treatment for multiple myeloma...
23 May 2016 | By Victoria White, Digital Content Producer
Researchers have identified a protein 'brake' within Natural Killer cells that controls their ability to destroy their target tumour cells...
23 May 2016 | By Victoria White, Digital Content Producer
Harvard researchers have created a new platform for antibiotic discovery that, they say, may go a long way to solving the crisis of antibiotic resistance...
11 May 2016 | By Victoria White, Digital Content Producer
Pfizer has awarded a total of more than $1 million in funding to five leading advocacy organisations to support metastatic breast cancer scientific research...
10 May 2016 | By Victoria White, Digital Content Producer
Scientists have designed a drug candidate, Targaprimir-96, that decreases the growth of tumour cells in animal models of triple negative breast cancer...
10 May 2016 | By Victoria White, Digital Content Producer
Scientists have designed dozens of molecular “warheads” that can detect a key biomarker of cancer and could be developed into a new class of drug candidates...
10 May 2016 | By Victoria White, Digital Content Producer
We discuss Innate Defense Regulator (IDR) technology with Soligenix's Chief Scientific Officer, Dr Oreola Donini, and find out more about SGX942...
